162 related articles for article (PubMed ID: 31014325)
1. What does it cost to redispense unused medications in the pharmacy? A micro-costing study.
Bekker CL; Gardarsdottir H; Egberts ACG; Molenaar HA; Bouvy ML; van den Bemt BJF; Hövels AM
BMC Health Serv Res; 2019 Apr; 19(1):243. PubMed ID: 31014325
[TBL] [Abstract][Full Text] [Related]
2. Patient and medication factors associated with preventable medication waste and possibilities for redispensing.
Bekker CL; van den Bemt BJF; Egberts ACG; Bouvy ML; Gardarsdottir H
Int J Clin Pharm; 2018 Jun; 40(3):704-711. PubMed ID: 29721736
[TBL] [Abstract][Full Text] [Related]
3. Cost Savings and Waste Reduction Through Redispensing Unused Oral Anticancer Drugs: The ROAD Study.
Smale EM; van den Bemt BJF; Heerdink ER; Desar IME; Egberts TCG; Bekker CL;
JAMA Oncol; 2024 Jan; 10(1):87-94. PubMed ID: 37971730
[TBL] [Abstract][Full Text] [Related]
4. Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey.
Bekker C; van den Bemt B; Egberts TC; Bouvy M; Gardarsdottir H
BMJ Open; 2019 May; 9(5):e024767. PubMed ID: 31092644
[TBL] [Abstract][Full Text] [Related]
5. Taking stock of medication wastage: Unused medications in US households.
Law AV; Sakharkar P; Zargarzadeh A; Tai BW; Hess K; Hata M; Mireles R; Ha C; Park TJ
Res Social Adm Pharm; 2015; 11(4):571-8. PubMed ID: 25487420
[TBL] [Abstract][Full Text] [Related]
6. Operation Donate: defining the value of redispensing medications donated by individuals.
Glanville M; Brady R; Miller S
J Am Pharm Assoc (2003); 2014; 54(5):542-7. PubMed ID: 25216885
[TBL] [Abstract][Full Text] [Related]
7. Redispensing of medicines unused by patients: a qualitative study among stakeholders.
Bekker CL; Gardarsdottir H; Egberts TC; Bouvy ML; van den Bemt BJ
Int J Clin Pharm; 2017 Feb; 39(1):196-204. PubMed ID: 28070689
[TBL] [Abstract][Full Text] [Related]
8. Measurement of unused medication in Medicare Part D residents in skilled nursing facilities.
Bazalo G; Weiss RC
Consult Pharm; 2011 Sep; 26(9):647-56. PubMed ID: 21896471
[TBL] [Abstract][Full Text] [Related]
9. Investigating unused medications in New Zealand.
Braund R; Gn G; Matthews R
Pharm World Sci; 2009 Dec; 31(6):664-9. PubMed ID: 19707885
[TBL] [Abstract][Full Text] [Related]
10. Redispensing of expensive oral anticancer medicines: A practical application.
Akgöl K; van Merendonk LN; Barkman HJ; van Balen DE; van den Hoek HL; Klous MG; Hendrikx JJ; Huitema AD; Beijnen JH; Nuijen B
J Oncol Pharm Pract; 2024 Apr; 30(3):519-526. PubMed ID: 37192749
[TBL] [Abstract][Full Text] [Related]
11. Key factors underlying the willingness of patients with cancer to participate in medication redispensing.
Smale EM; Egberts TCG; Heerdink ER; van den Bemt BJF; Bekker CL
Res Social Adm Pharm; 2022 Aug; 18(8):3329-3337. PubMed ID: 34973931
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Disposed Unused Medications at a Village Community Pharmacy.
Vella V; West LM
Pharmacy (Basel); 2019 May; 7(2):. PubMed ID: 31083620
[No Abstract] [Full Text] [Related]
13. Pharmacy performance while providing continuous medication monitoring.
Doucette WR; McDonough RP; Herald F; Goedken A; Funk J; Deninger MJ
J Am Pharm Assoc (2003); 2017; 57(6):692-697. PubMed ID: 28844583
[TBL] [Abstract][Full Text] [Related]
14. Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy.
Bekker CL; Melis EJ; Egberts ACG; Bouvy ML; Gardarsdottir H; van den Bemt BJF
Res Social Adm Pharm; 2019 Jan; 15(1):100-105. PubMed ID: 29610051
[TBL] [Abstract][Full Text] [Related]
15. Actual versus recommended storage temperatures of oral anticancer medicines at patients' homes.
Vlieland ND; van den Bemt B; van Riet-Nales DA; Bouvy ML; Egberts A; Gardarsdottir H
J Oncol Pharm Pract; 2019 Mar; 25(2):382-389. PubMed ID: 29187027
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of a medication review with follow-up service for older adults with polypharmacy in community pharmacies in Spain: the conSIGUE program.
Jódar-Sánchez F; Malet-Larrea A; Martín JJ; García-Mochón L; López Del Amo MP; Martínez-Martínez F; Gastelurrutia-Garralda MA; García-Cárdenas V; Sabater-Hernández D; Sáez-Benito L; Benrimoj SI
Pharmacoeconomics; 2015 Jun; 33(6):599-610. PubMed ID: 25774017
[TBL] [Abstract][Full Text] [Related]
17. Pharmaceutical services cost analysis using time-driven activity-based costing: A contribution to improve community pharmacies' management.
Gregório J; Russo G; Lapão LV
Res Social Adm Pharm; 2016; 12(3):475-85. PubMed ID: 26365300
[TBL] [Abstract][Full Text] [Related]
18. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
Erickson SR; Workman P
J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
[TBL] [Abstract][Full Text] [Related]
19. Quantification of an ongoing community-based medication take-back program.
Perry LA; Shinn BW; Stanovich J
J Am Pharm Assoc (2003); 2014; 54(3):275-9. PubMed ID: 24816354
[TBL] [Abstract][Full Text] [Related]
20. Cost analysis for the implementation of a medication review with follow-up service in Spain.
Noain A; Garcia-Cardenas V; Gastelurrutia MA; Malet-Larrea A; Martinez-Martinez F; Sabater-Hernandez D; Benrimoj SI
Int J Clin Pharm; 2017 Aug; 39(4):750-758. PubMed ID: 28434119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
